# 0.005% Latanoprost Gel for Nonsegmental Vitiligo

> **NCT07016113** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Universitas Padjadjaran** · enrollment: 10 (estimated)

## Conditions studied

- Vitiligo - Macular Depigmentation

## Interventions

- **DRUG:** 0.005% latanoprost gel
- **DRUG:** 0.1% mometasone furoate cream

## Key facts

- **NCT ID:** NCT07016113
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-11-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016113, "0.005% Latanoprost Gel for Nonsegmental Vitiligo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07016113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*